Proteome Sciences plc (AIM:PRM)
London · Delayed Price · Currency is GBP · Price in GBX 1.400
0.00 (0.00%)
Apr 17, 2026, 4:35 PM GMT
Proteome Sciences Market Cap
Proteome Sciences has a market cap or net worth of 4.91 million as of April 17, 2026. Its market cap has decreased by -59.03% in one year.
Market Cap
4.91M
Enterprise Value
19.90M
Revenue
3.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.40
Market Cap Chart
Since March 1, 1999, Proteome Sciences's market cap has decreased from 11.17M to 4.91M, a decrease of -56.05%. That is a compound annual growth rate of -2.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 4.91M | -33.46% |
| Dec 31, 2025 | 7.38M | -26.47% |
| Dec 31, 2024 | 10.04M | -24.94% |
| Dec 29, 2023 | 13.37M | 29.43% |
| Dec 30, 2022 | 10.33M | -31.71% |
| Dec 31, 2021 | 15.13M | 32.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.02B |
| GSK plc | 85.13B |
| Haleon | 31.48B |
| Smith & Nephew | 10.78B |
| CRISM Therapeutics | 6.08M |
| OptiBiotix Health | 5.47M |
| Feedback | 5.41M |
| Theracryf | 4.84M |